Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Hepatocyte growth factor attenuates intimal hyperplasia in rabbit arterial injury model

June 21, 2000

Combination therapy for heart failure

June 20, 2000

Millennium and Lilly extend cardiovascular collaboration

June 20, 2000

Phase II trial of Genentech's anti-CD18 antibody fails to meet primary objectives

June 19, 2000

Selective iNOS inhibitors in early development at the newly formed Pharmacia

June 15, 2000

Potent new MMP inhibitor series patented by ADIR

June 15, 2000

Antihypertensive combination of lacidipine and telmisartan superior to monotherapies

June 15, 2000

Potent and selective human red blood cell IK(Ca) channel blockers reported at ASBMB/ASPET

June 15, 2000

ADA news: glycogen phosphorylase inhibitor displays hypoglycemic and cardioprotective effects

June 15, 2000

Study confirms VasoCare's ability to improve blood vessel function in atherosclerosis

June 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...